Fibroscan Doctors Abroad — Page 3

Prof. Dr. Gül Alço is a radiation oncologist with about 27 years of experience. She treats breast, lung, prostate, gastrointestinal, gynecologic, central nervous system, head and neck, soft tissue, and bone cancers with radiotherapy.

Her expertise includes adaptive radiotherapy and radiosurgery. She uses advanced radiation techniques to provide personalized, evidence-based care in a multidisciplinary, patient-centered setting.

Dr. Shaunak Valame is a medical oncologist at the HCG Manavata Cancer Centre. He manages gastrointestinal cases where Fibroscan helps assess liver health during chemotherapy.

• Earned a DNB in Medical Oncology from Indraprastha Apollo Hospital
• Presented research on stomach cancer to the American Society of Clinical Oncology
• Specializes in chemotherapy protocols for solid tumors and gastrointestinal malignancies
• Member of the American Society of Clinical Oncology (ASCO)
• Former lecturer for the International Winter School of Oncology at AIIMS

Professor Park Jung-won is a leading Korean specialist in hepatocellular carcinoma with over 30 years of experience. He is the Director of the Liver and Liver Cancer Center and the Integrated Cancer Care Center at Myongji Hospital. He led Korea’s first HCC guidelines in 2003. He has also overseen their updates for about 20 years. His team validated proton beam radiotherapy for liver cancer, as published in the Journal of Hepatology. He has authored more than 200 SCI-indexed papers. He also helped lead global trials, including the 2025 CheckMate 9DW study, which showed improved outcomes with nivolumab plus ipilimumab for unresectable HCC.

MD/PhD, Seoul National University; Member, National Academy of Medicine of Korea; former President, Korean Liver Cancer Association; Chair, Korean HCC Guidelines Committee; Prime Minister’s and Health Minister’s commendations; Pfizer Medical Research Award and Roche Oncology Academic Award.

Prof. Dr. İbrahim Doğan is a gastroenterologist. He earned his MD from Ankara University Faculty of Medicine in 1991. He became an Internal Medicine specialist at Gazi University in 1996. He completed gastroenterology subspecialty training at İnönü University in 2001.

His academic career was at Gazi University. He served as Lecturer (2002), Assistant Professor (2003), Associate Professor (2007), and Professor (2012). He worked as a researcher at the University of California San Diego from 2004 to 2006. He has practiced at Koru Hospital since January 2023.

Clinical focus includes gastroesophageal reflux, irritable bowel syndrome, constipation, gastroparesis, achalasia, bloating, gas and belching, fecal incontinence, ulcerative colitis, and Crohn’s disease. He performs ERCP, stent placement, balloon and bougie dilation, polypectomy, argon plasma coagulation, double-balloon enteroscopy, and bleeding control.

Professor Lee Seok-gu is a leading liver transplant surgeon at Myongji Hospital. He has performed about 2,000 liver transplants. He achieved Korea’s first transfusion-free liver transplant. He performed hepatocyte transplantation in a one-month-old infant. He led the first clinical use of a bioartificial liver for acute liver failure. He also performed living-donor transplants in Egypt and trained teams in Vietnam.

He is Professor of Surgery at Myongji Hospital and former Director of the Organ Transplantation Center at Samsung Medical Center. He earned his MD and MSc from Seoul National University and his PhD from the Catholic University of Korea. He completed a fellowship at Boston Children’s Hospital/Harvard and transplant training at Johns Hopkins. He served as president of three national societies in transplantation and pediatric surgery. His honors include the Chong Kun Dang Award, the Pfizer Clinical Medicine Award, and the Astellas Investigator Award. He has 447 publications and 13 book chapters.

Dr. Nihat Okcu is a gastroenterologist and gastrointestinal surgeon at Medipol University Pendik Hospital. He specializes in the treatment of complex digestive conditions and liver diseases. Dr. Okcu has published over 20 academic papers on gastric cancer and endoscopic diagnosis. He serves at a hospital with a 95.4% healthcare quality score.

• Performs laparoscopic anti-reflux surgery and small intestine resections.
• Expert in gastric polyps removal and duodenal polyp excision.
• Treats chronic conditions like cirrhosis, Crohn’s disease, and ulcerative colitis.
• Provides diagnostic gastroscopy with biopsy and ultrasound-guided procedures.

Dr. Antonio Cubillo Gracián leads the Medical Oncology Service at HM Sanchinarro. He uses Fibroscan to assess liver health in patients with digestive and gastrointestinal cancers.

• Director of Postgraduate Research at HM CIOCC – a leading cancer research center
• Pioneered liquid biopsy programs to analyze tumor genetics through simple blood tests
• Specializes in stage 2–4 cancers of the liver, stomach, and colon
• Associate Professor of Oncology teaching pathology and digestive system diseases
• Directs clinical trials for new cancer therapies through the Start Madrid program

Professor Kayihan Engin is the Director of Oncological Sciences at Medicana Bursa Hospital. He manages gastrointestinal cases including liver and pancreas tumors that may require Fibroscan monitoring.

• Completed a post-doctoral fellowship in thermoradiotherapy at Thomas Jefferson University in the USA
• Specializes in gastrointestinal tumors including liver cancers and liver metastases
• Former Chairman of Radiation Oncology at Uludağ University Medical College
• Conducted research on cancer risks at the National Cancer Institute in the USA
• Expert in CyberKnife robotic systems for precise targeting of localized tumors

Prof. Dr. Musa Aydınlı is an internal medicine specialist and gastroenterologist. He completed his MD at Hacettepe University in 1997. He finished internal medicine training in 2003 and gastroenterology training in 2007 at the same institution. He worked at Kayseri Training and Research Hospital from 2007 to 2009. He served in the Gastroenterology Department at Gaziantep University from 2009 to 2014. He became an associate professor in 2012 and a professor in 2020. He joined Gülhane Training and Research Hospital in 2022. He now practices at Private Koru Ankara Hospital.

Clinical focus: GERD; dyspepsia, gastritis, and Helicobacter pylori; peptic ulcer disease; celiac disease; IBS and IBD (ulcerative colitis, Crohn’s disease); colon polyps; colorectal and upper GI cancers; liver disease (fatty liver, chronic hepatitis, cirrhosis, portal hypertension); hepatobiliary and pancreatic disorders and cancers. Procedures: EGD, rectosigmoidoscopy, and colonoscopy; biopsy, polypectomy, and endoscopic mucosal resection; hemostasis and APC; dilation and stent placement; PEG; ERCP; EUS-guided biopsy.

With 50,000 cancer surgeries performed, Dr. Nagarkar is the Chief of Surgical Oncology at HCG Manavata Cancer Centre. His oncologic work includes liver assessments using Fibroscan to evaluate organ health.

• Trained in surgical oncology at Tata Memorial Hospital in Mumbai
• Member of the Royal College of Surgeons of Edinburgh in the UK
• Treats complex liver and colorectal cancers using advanced surgical techniques
• Participated in over 200 clinical trials to advance cancer treatment
• Professor for superspecialty surgical oncology training future doctors

The doctor graduated with a Bachelor of Medicine from Mysore University in 1996, followed by a Doctor of Medicine in radiotherapy from Banaras Hindu University in 2002. Further enhancing expertise, the doctor earned a Diplomate of National Board in radiotherapy in 2004.

The doctor is a member of several prestigious organizations, including the Association of Radiation Oncology of India, the Society for Neuro-Oncology, the Bangalore Oncology Group, and the Indian Association of Hyperthermia Oncology, reflecting a strong commitment to advancing the field of oncology.

Dr. Chaitainya Borde has handled more than 30,000 PET scans. He leads nuclear medicine services at HCG Manavata Cancer Centre.

• Expert in nuclear scans including Fibroscan for liver assessment
• Performed therapy for 1,000 thyroid cancer patients
• Proficient in nuclear cardiology services for heart health
• Published research papers in various medical journals
• Specializes in Lu-177 RN therapies for advanced cancer cases

Dr. Shruti Kate is the Head of Department at HCG Manavata Cancer Centre. She provides expert oncology care and liver health monitoring using Fibroscan technologies.

• Previously served as a consultant at Tata Memorial Hospital in Mumbai
• Expertise includes treating solid tumors and various blood cancers
• Recipient of the solo travel award from India at WCLC 2018
• Member of the American Society of Clinical Oncology (ASCO)
• Qualified with a DM in Medical Oncology from Tata Memorial Hospital